Losses in health and productivity from obesity 'far outweigh the cost of weight-loss injections' | Obesity

The rising health care costs and lost productivity caused by the global obesity crisis New weight loss drugsThe report urges governments to prioritise prevention by promoting healthy eating and exercise.

The UK, Germany and NetherlandsThe report said the drugs have a clear economic case, as the annual cost of the diabetes drug Ozempic is lower than the extra medical care that obese people require. Research by ING Bank seen by the Guardian found that the cost of the weight-loss injectable Wegovy is higher, but still small compared with the overall economic cost of obesity to society.

Both drugs, made by Danish pharmaceutical company Novo Nordisk, are hugely popular, along with Eli Lilly's Zepbound and Maunjaro. Administered as a weekly injection, they mimic a gut hormone called GLP-1, which makes you feel full and helps you lose weight. Recent studies have shown they may also have other health benefits.

Obesity rates have risen sharply over the past few decades, with more people in the world now overweight than malnourished. A new wave of GLP-1 drugs could help reverse this trend, but questions remain about how long their effects will last. Expensive priceEspecially Wegovy.

Obesity is associated with health problems such as cardiovascular disease, joint problems and diabetes, all of which are costly to treat.

ING healthcare analyst Diederik Stadig calculates that the overall cost of obesity in the UK is £100 billion a year, of which £19 billion goes to the NHS. Health costs are €1,700 (£1,400) and €2,400 per person per year. GermanyIn the Netherlands it is 2,300 euros and in the US it is 2,500 euros.

A year's supply of Ozempic, which is also prescribed for weight loss, costs £830 in the UK and £2,760 for a year's supply of Wegovy, compared to €1,100 in Germany and the Netherlands and €10,100 in the US. A year's supply of Wegovy costs €3,500 in Germany, €3,200 in the Netherlands and €14,500 in the US, where drugs are generally more expensive.

The analysis is based on list price, which is often higher than the actual price paid.

Health care costs account for about a quarter of the total cost of obesity to society, Stadig said, which also includes lost economic productivity and personal expenses such as extra transportation, clothing and assisted living facilities for obese people.

“If the drug works in the long term, it will enable people to lead healthier lives, reduce lost productivity, reduce personal burden and improve quality of life. If we can prevent obesity in many people, it will not only reduce a lot of discomfort for people but also save society money,” he said.

A recent study conducted by the Institute for Advanced Studies in Vienna across 26 European countries found that obese people are up to twice as likely to miss work.

“Obesity can lead to more than 80 diseases, from depression to heart attacks,” said Thomas Cipionca, head of the institute's Health Economics and Health Policy research group. “Obese people take more sick days. There are labour shortages across Europe, so this is a big problem for the economy.”

Skip Newsletter Promotions

After newsletter promotion

He predicts that prices for obesity drugs will fall in the coming years. More medicines coming to marketBut for now, the government needs to prioritise those most at risk.

Stadig cautioned that the long-term effects of these drugs are uncertain. One study showed that stopping semaglutide, the active ingredient in Ozempic and Wegovi, I've lost two-thirds of my body weight Many people who take the medication for less than a year experience side effects such as nausea and stomach pains, so they stop taking it after a while.

Doctors tend to prescribe weight loss drugs in conjunction with diet and exercise plans, The government needs to put more effort into fighting obesity“We're using the VAT as a way to encourage healthy eating, with no or only a small VAT on vegetables and a higher tax on fast food,” Stadig said.

A number of celebrities have spoken out about their use of semaglutide, including Australian actor Rebel Wilson. Tried Ozempic for a short period to maintain weight After losing six stone through dietary changes and exercise, announcer and actor Stephen Fry He vomited up to five times a day.and TV personality Sharon Osbourne He told the Guardian in February She lost three stone in four months by using Ozempic injections but is now struggling to gain weight.